FE Seminar Series - Stephen Markscheid "US Listed Chinese Companies - An Insider's View"
Thursday, December 5, 2013 – 5:00 pm
Location: Babbio 122
US Listed Chinese Companies - An Insider's View
Chief Executive Office, Synergenz BioScience, Inc.
More than 400 Chinese companies listed their shares on US exchanges, through both IPO and RTO ('reverse takeover') routes. Beginning in 2010, many of these companies were accused of fraud. The entire sector collapsed in price, many firms were delisted, and shareholders sued company managements and boards. What went wrong? What can we learn from this experience?
Stephen Markscheid is Chief Executive Officer of Synergenz BioScience, Inc. a genomics company based in Hong Kong. He serves as an non-executive director of CNinsure, Inc., Jinko Solar Inc., China Integrated Energy, Inc., China Ming Yang Wind Group Co. Ltd., and ChinaCast Education Corporation. Steve is also a trustee on the board of Princeton-in-Asia.
From 1998-2006, Steve worked for GE Capital. During his time with GE, Steve led GE Capital's business development activities in China and Asia Pacific, primarily acquisitions and direct investments. Prior to GE, Steve worked with the Boston Consulting Group throughout Asia. Steve was also a commercial banker for ten years in London, Chicago, New York, Hong Kong and Beijing with Chase Manhattan Bank and First National Bank of Chicago. His career began with the US-China Business Council, in Washington D.C. and Beijing.
Steve holds an MBA from Columbia University, an M.A. in International Affairs from Johns Hopkins SAIS, and a B.A. in East Asian Studies from Princeton University. He lived and worked in Asia for over sixteen years, including China, Singapore, Hong Kong, Taiwan, and Thailand. Besides his native English, Steve is fluent in Chinese and conversant in Japanese and French.
Steve lives with his wife, Veronique, and three children in suburban Chicago.